H.C. Wainwright raised the firm’s price target on electroCore (ECOR) to $22 from $15 and keeps a Buy rating on the shares after the firm ...
Electrocore (ECOR – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Swayampakula ...
The lawsuit is the second by a large drugmaker in recent days challenging how it provides required discounts to certain hospitals.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback